References
Weide B, Eigentler TK, Pflugfelder A, Leiter U, Meier F, Bauer J et al (2011) Survival after intratumoral interleukin-2 treatment of 72 melanoma patients and response upon the first chemotherapy during follow-up. Cancer Immunol Immunother 60:487–493. doi:10.1007/s00262-010-0957-3
Weide B, Derhovanessian E, Pflugfelder A, Eigentler TK, Radny P, Zelba H et al (2010) High response rate after intratumoral treatment with interleukin-2. Cancer 116:4139–4146. doi:10.1002/cncr.25156
Dehesa LA, Vilar-Alejo J, Valeron-Almazan P, Carretero G (2009) Experience in the treatment of cutaneous in transit melanoma metastases and satellitosis with intralesional interleukin-2. Actas Dermosifiliogr 100:571–585
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moreno-Ramírez, D., Alés-Martínez, M. & Ferrándiz, L. Fast-growing in-transit melanoma metastasis after intratumoral interleukin-2. Cancer Immunol Immunother 63, 1229–1230 (2014). https://doi.org/10.1007/s00262-014-1583-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-014-1583-2